Fifth Third Bancorp
PACB icon

Fifth Third Bancorp’s Pacific Biosciences PACB Stock Holding History

Fifth Third Bancorp’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53K Sell
1,508
-319
-17% -$464 ﹤0.01% 4053
2026
Q1 		$2.41K Buy
+1,827
New +$3.27K ﹤0.01% 4003
2023
Q1 		– Sell
-400
Closed -$3.27K – 2817
2022
Q4 		$3.27K Hold
400
– – ﹤0.01% 2334
2022
Q3 		$2K Hold
400
– – ﹤0.01% 2455
2022
Q2 		$2K Buy
+400
New +$2.43K ﹤0.01% 2452

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fifth Third Bancorp's PACB Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Pacific Biosciences (PACB) stake by 17% in Q2 2026, selling an estimated $464 and leaving 1,508 shares worth $2.53K. The position accounts for ﹤0.01% of the portfolio, ranked #4053.

Fifth Third Bancorp first reported a position in PACB in Q2 2022 and has held it in 5 quarters since. The position peaked at $3.27K in Q4 2022. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Fifth Third Bancorp held 1,508 shares of Pacific Biosciences worth $2.53K as of Q2 2026.
  • Fifth Third Bancorp sold 319 Pacific Biosciences shares in Q2 2026, an estimated $464.
  • Pacific Biosciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4053 holding.
  • Fifth Third Bancorp first reported a position in Pacific Biosciences in Q2 2022 and has held it in 5 quarters since.
  • Fifth Third Bancorp's Pacific Biosciences position peaked at $3.27K in Q4 2022.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.